News

University Hospital Hamburg-Eppendorf Leads Trial to Explore Personalized Medicine in COVID-19

April 12, 2022

Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for treatment of COVID-19.

Opus Enters Collaboration with Resilience for AAV-Based Gene Therapy Development and Manufacturing

April 12, 2022

Opus enters a strategic collaboration with Resilience for AAV-based gene therapy development and manufacturing for inherited retinal diseases.

Orchard Therapeutics Announces Reimbursement Agreement for Libmeldy

April 12, 2022

Orchard Therapeutics announces reimbursement agreement, which will make Libmeldy available for all eligible MLD patients in Italy.

EC Approves Dupixent for Treatment of Severe Asthma in Young Children

April 12, 2022

Dupixent has been approved by the EC for children aged 6 to 11 years with severe asthma with type 2 inflammation.

Ymmunobio AG Signs Patent Purchase Agreement with LeukoCom GmbH

April 11, 2022

Ymmunobio AG has signed a patent purchase agreement with LeukoCom GmbH to expand its development of cancer therapies.

Legislation Targets High Cost of Clinical Trials

April 11, 2022

Democrats have proposed a measure to facilitate access to less costly comparator drugs needed in clinical trials, while another bill aims to increase transparency in the costs of clinical trials.

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

April 11, 2022

Pfizer plans to acquire ReViral and its respiratory syncytial virus therapeutic candidates to strengthen Pfizer’s capabilities in infectious disease research.

Lonza and Asher Biotherapeutics to Collaborate on Manufacturing AB359

April 11, 2022

Lonza and Asher Biotherapeutics have entered a manufacturing agreement for a cis-targeted IL-2 fusion protein, AB359.

IAVI and Moderna Partner to Tackle Global Health Priorities Using mRNA for Vaccines and Antibodies

April 11, 2022

IAVI and Moderna have announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health issues.

Evonetix Receives Patent for Thermally-Controlled DNA Synthesis Technology

April 08, 2022

Evonetix’s thermally controlled DNA synthesis technology is designed to enable highly parallel DNA synthesis in a benchtop platform.